
As children return to the classroom, clear distance vision becomes essential for reading the board, following presentations, participating in sports, and moving confidently through the school day. If your child’s glasses prescription keeps getting stronger, the issue may be progressive myopia rather than a one-time change in vision.
Myopia management gives McKinney families options beyond simply updating glasses each year. These treatments are designed to slow the progression of nearsightedness while providing the clear vision children need for school and daily activities.
Myopia, also called nearsightedness, causes distant objects to appear blurry while close-up objects remain clearer. It commonly develops during childhood and can continue progressing while the eyes are still growing. A child may begin having trouble seeing the classroom board, recognizing faces from across a room, or following the action during sports.
Standard glasses correct blurry vision, but myopia management addresses how quickly the condition progresses. Slowing that progression can reduce the likelihood of a child developing a much stronger prescription later.
Children do not always realize that their distance vision has become blurry. McKinney parents should watch for behaviors such as:
A comprehensive eye exam is the best way to determine whether your child has myopia and whether the prescription is progressing.
No single treatment is right for every child. At DeNovo Eye, we evaluate your child’s prescription, eye health, age, lifestyle, treatment history, and ability to manage contact lenses before recommending an approach.
Orthokeratology, commonly called Ortho-K, uses custom gas-permeable lenses worn while sleeping. The lenses temporarily reshape the front surface of the eye so the child can often see clearly during the day without glasses or daytime contacts. Ortho-K is also used to help slow myopia progression.
MiSight 1 Day lenses are daily disposable soft contact lenses created to correct nearsightedness and slow its progression. The FDA indication covers eligible children who begin treatment between ages 8 and 12 and meet specific prescription and eye health requirements.
Low-dose atropine eye drops and other specialty multifocal contact lenses may also be considered based on the child’s clinical findings. DeNovo Eye offers multiple myopia management options, including Ortho-K, atropine therapy, MiSight, and specialty contact lenses.
Back-to-school routines place greater demands on a child’s distance and near vision. An evaluation at the beginning of the school year establishes an updated prescription and gives parents a clearer picture of whether myopia is progressing.
Starting a personalized plan early also allows the doctor to monitor changes over time. Follow-up visits are an important part of myopia management because they help us assess vision, eye health, lens fit, prescription changes, and treatment response.
Myopia management works alongside healthy visual habits. Research supports spending more time outdoors as a way to reduce the risk of developing myopia, particularly among children who are not yet nearsighted. Outdoor time may also provide additional support for children already receiving treatment.
Children should also take regular breaks from homework and digital devices, avoid holding screens too close, and use adequate lighting during reading. These habits do not replace professional treatment, but they support visual comfort throughout the school year.
Schedule your child’s myopia management evaluation with DeNovo Eye at 6675 S. Custer Road, Suite 600, McKinney, TX 75070. Call or text (469) 317-2020 to book an appointment.